The company’s second platform is a thermostable technology that enables the development of vaccines and biologics that can withstand storage or shipment at constantly fluctuating temperatures. VBI has completed proof of concept thermostability studies on a number of vaccine and biologic targets.
|Size (employees)||98 (est)+12%|
Gross profit (Q3, 2018)
Gross profit margin (Q3, 2018), %
Net income (Q3, 2018)
EBIT (Q3, 2018)
Market capitalization (4-Dec-2018)
Closing stock price (4-Dec-2018)
When was VBI Vaccines founded?
VBI Vaccines was founded in 2001.
How many employees does VBI Vaccines have?
VBI Vaccines has 98 employees.
What is VBI Vaccines revenue?
Latest VBI Vaccines annual revenue is $865 k.
What is VBI Vaccines revenue per employee?
Latest VBI Vaccines revenue per employee is $8.8 k.
Who are VBI Vaccines competitors?
Competitors of VBI Vaccines include Alnylam Pharmaceuticals, Sorrento Therapeutics and Pernix Therapeutics.
Where is VBI Vaccines headquarters?
VBI Vaccines headquarters is located at 2241 222 Third St, Cambridge.
Where are VBI Vaccines offices?
VBI Vaccines has offices in Cambridge, Rehovot and Ottawa.
How many offices does VBI Vaccines have?
VBI Vaccines has 3 offices.